IL157607A0 - Methods for the preparation of mirtazapine intermediates - Google Patents

Methods for the preparation of mirtazapine intermediates

Info

Publication number
IL157607A0
IL157607A0 IL15760702A IL15760702A IL157607A0 IL 157607 A0 IL157607 A0 IL 157607A0 IL 15760702 A IL15760702 A IL 15760702A IL 15760702 A IL15760702 A IL 15760702A IL 157607 A0 IL157607 A0 IL 157607A0
Authority
IL
Israel
Prior art keywords
preparation
methods
mirtazapine
intermediates
mirtazapine intermediates
Prior art date
Application number
IL15760702A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL157607A0 publication Critical patent/IL157607A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15760702A 2001-03-01 2002-02-14 Methods for the preparation of mirtazapine intermediates IL157607A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27269901P 2001-03-01 2001-03-01
PCT/US2002/004340 WO2002070513A1 (en) 2001-03-01 2002-02-14 Methods for the preparation of mirtazapine intermediates

Publications (1)

Publication Number Publication Date
IL157607A0 true IL157607A0 (en) 2004-03-28

Family

ID=23040907

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15760702A IL157607A0 (en) 2001-03-01 2002-02-14 Methods for the preparation of mirtazapine intermediates

Country Status (10)

Country Link
US (1) US6774230B2 (xx)
EP (1) EP1370549A4 (xx)
JP (1) JP2005501808A (xx)
KR (1) KR20030078086A (xx)
CA (1) CA2438446A1 (xx)
IL (1) IL157607A0 (xx)
IS (1) IS6928A (xx)
NO (1) NO20033840D0 (xx)
PL (1) PL374044A1 (xx)
WO (1) WO2002070513A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
EP3261645B1 (en) 2015-02-27 2021-04-28 Dechra Limited Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
AU6474200A (en) 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound

Also Published As

Publication number Publication date
US6774230B2 (en) 2004-08-10
EP1370549A4 (en) 2005-03-09
WO2002070513A9 (en) 2002-11-21
US20020165238A1 (en) 2002-11-07
CA2438446A1 (en) 2002-02-14
PL374044A1 (en) 2005-09-19
JP2005501808A (ja) 2005-01-20
WO2002070513A1 (en) 2002-09-12
EP1370549A1 (en) 2003-12-17
IS6928A (is) 2003-08-27
NO20033840D0 (no) 2003-08-29
KR20030078086A (ko) 2003-10-04

Similar Documents

Publication Publication Date Title
IL200255A (en) Method of preparing o-desmethyl-venlafaxine
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
IL146389A0 (en) Process for the preparation of dronedarone
HK1068887A1 (en) Method for the preparation of hexahydro-furo
PL366584A1 (en) Compounds useful as intermediates
EP1425279A4 (en) PROCESS FOR THE PREPARATION OF CRYSTALLINE TETRAHYDROBENZOTHIEPINES
IL159183A0 (en) Method for the preparation of escitalopram
IL161714A0 (en) Method for the preparation of escitalopram
IL146598A0 (en) Method for the preparation of aggregates
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
HUP0600231A2 (en) Novel process for the preparation of 2h-chromenes
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
IL157607A0 (en) Methods for the preparation of mirtazapine intermediates
HUP0401921A3 (en) Intermediate compounds for the preparation of mirtazapine and the production methods thereof
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
IL164788A0 (en) Process for the preparation of 3-isochromanone
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
PT1622926E (pt) Novo processo e intermediários de preparação de compostos 19-nor-esteróides-17-halogéneo
HK1087111A1 (en) Process for the preparation of nicotinaldehydes
SI1385850T1 (en) New process for the preparation of oxabispidines
HU0300255D0 (en) Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine
GB0105878D0 (en) Novel process for the preparation of pyrazoloprimidinones